Hyperfine Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Hyperfine Inc inventory turnover ratio, the Hyperfine Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.06 in the second quarter 2026, HYPR's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Hyperfine Inc in Jun 30 2026 quarter, has decreased to 344 days, compare to 369 days, in the Mar 31 2026 quarter.

Within Healthcare sector 308 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2026, to 1825, from total ranking in the first quarter 2026 at 1969.

HYPR Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Hyperfine Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

HYPR Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	39.06 %	36.39 %	21.57 %	-17.12 %	-34.6 %
Y / Y Cost of Sales Growth	92.4 %	0 %	0 %	0 %	0 %
Inventory Turnover Ratio (TTM)	1.06	0.99	1.07	1.13	1.07
HYPR's Total Ranking	# 1825	# 1969	# 1870	# 1877	# 1920
Average inventory processing period	343	367	341	322	341
Seq. Inventory Growth	7.3 %	-10.76 %	21.45 %	19.58 %	5.24 %
Seq. Cost of Sales Growth	92.4 %	-66.67 %	200 %	0 %	0 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 142
Healthcare Sector	# 309
Overall Market	# 1825

Inventory Turnover Ratio Statistics
High	Average	Low
1.7	1.01	0.66
(Sep 30 2022)		(Sep 30 2024)

HYPR Company Profile >> Back to HYPR Efficiency Comparisons >> Compare HYPR Inventory Turnover Ratio to its Competitors

Financial Statements
Hyperfine Inc 's Inventories	$ 7 Millions	Visit HYPR's Balance sheet
Hyperfine Inc 's Cost of Revenues TTM	$ 7 Millions	Visit HYPR's Income Statement
What are HYPR's Sales?		Visit HYPR's Sales by Segment

Other Inventory Turnover Ratios
Hyperfine Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
HYPR's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for HYPR's Competitors
Inventory Turnover Ratio for HYPR's Suppliers
Inventory Turnover Ratio for HYPR's Customers

You may also want to know
HYPR's Sales Growth Rates	HYPR's Pe Price to earnings ratio	HYPR's Receivables Turnover Ratio	HYPR's Stock Quote
HYPR's Net Income Growth Rates	HYPR's Ps Price to Sales ratio	HYPR's Sales per Employee	HYPR's Asset Turnover Ratio
HYPR's Net Margin	HYPR's Pb Price to Book ratio	HYPR's Financial Strength Ratios	HYPR's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Merck and Co Inc	2.79	$ 17,996.000 Millions	$ 6,447 Millions
Inspiremd Inc	2.78	$ 8.847 Millions	$ 3 Millions
Dentsply Sirona Inc	2.77	$ 1,839.000 Millions	$ 663 Millions
Ani Pharmaceuticals Inc	2.69	$ 387.398 Millions	$ 144 Millions
International Stem Cell Corporation	2.61	$ 4.285 Millions	$ 2 Millions
Biomerica Inc	2.59	$ 4.091 Millions	$ 2 Millions
Evofem Biosciences Inc	2.58	$ 4.418 Millions	$ 2 Millions
Nephros Inc	2.54	$ 8.991 Millions	$ 4 Millions
Illumina Inc	2.52	$ 1,510.000 Millions	$ 599 Millions
IMPACT BIOMEDICAL INC.	2.46	$ 0.414 Millions	$ 0 Millions
Quidelortho Corp	2.45	$ 1,481.500 Millions	$ 605 Millions
Pro dex Inc	2.43	$ 53.213 Millions	$ 22 Millions
Angiodynamics Inc	2.43	$ 142.834 Millions	$ 59 Millions
Cytosorbents Corporation	2.43	$ 10.584 Millions	$ 4 Millions
Journey Medical Corp	2.42	$ 23.556 Millions	$ 10 Millions
Aquestive Therapeutics Inc	2.42	$ 17.828 Millions	$ 7 Millions
Viatris Inc	2.41	$ 9,604.200 Millions	$ 3,993 Millions
Cannapharmarx Inc	2.37	$ 2.483 Millions	$ 1 Millions
Aurinia Pharmaceuticals Inc	2.34	$ 30.036 Millions	$ 13 Millions
Fortress Biotech Inc	2.34	$ 22.768 Millions	$ 10 Millions
Scientific Industries Inc	2.33	$ 4.057 Millions	$ 2 Millions
Insight Molecular Diagnostics Inc	2.31	$ 0.868 Millions	$ 0 Millions
Tela Bio Inc	2.30	$ 26.348 Millions	$ 11 Millions
Sanara Medtech Inc	2.29	$ 7.981 Millions	$ 3 Millions
China Pharma Holdings Inc	2.25	$ 3.450 Millions	$ 2 Millions
Beta Bionics Inc	2.23	$ 50.111 Millions	$ 22 Millions
Apyx Medical Corp	2.21	$ 21.014 Millions	$ 10 Millions
Medtronic Plc	2.21	$ 13,136.000 Millions	$ 5,950 Millions
Embecta Corp	2.19	$ 418.400 Millions	$ 191 Millions
Avita Medical Inc	2.18	$ 13.950 Millions	$ 6 Millions

Date modified: 2026-09-08T01:18:32+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.